Form 4: Biolife Solutions CFO Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Troy Wichterman, Chief Financial Officer of Biolife Solutions Inc, reported multiple transactions in common stock on October 6, 2026.

Summary

  • Grant/award: acquired 76,204 Common Stock on October 6, 2026; holds 216,881 after (Direct).
  • Grant/award: acquired 62,300 Common Stock on October 6, 2026; holds 279,181 after (Direct).
  • Tax/exercise-price withholding: disposed of 95,933 Common Stock at $38.61 ($3,703,973) on October 6, 2026; holds 183,248 after (Direct).
  • Disposition to the issuer: disposed of 256,000 Common Stock on October 6, 2026 (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Troy Wichterman — Officer (Chief Financial Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-10-06Grant/awardCommon Stock76,204——216,881
2026-10-06Grant/awardCommon Stock62,300——279,181
2026-10-06Tax/exercise-price withholdingCommon Stock95,933$39$3.7M183,248
2026-10-06Disposition to the issuerCommon Stock256,000——0

Key Dates

DateDescription
2026-10-06Grant/award (76,204 shares)
2026-10-06Grant/award (62,300 shares)
2026-10-06Tax/exercise-price withholding (95,933 shares)
2026-10-06Disposition to the issuer (256,000 shares)

Keywords

insider transaction, Form 4, BLFS, BIOLIFE SOLUTIONS INC, neutral, Troy Wichterman

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.